23andMe president steps down, will remain on the board

Andy Page, the president of at-home genetic testing service 23andMe, will leave the company in December but will remain on the company’s board of directors, Recode reports.

Advertisement

In a letter to employees, 23andMe CEO Anne Wojcicki wrote, “Andy and I recognize 23andMe is at a stage of strength and maturity where it would benefit from one single leader. Moving forward, Andy’s direct reports will report to me.”

Recode was not aware of where, if anywhere, Mr. Page plans to work next.

Mr. Page previously served as president of the Gilt Groupe, CFO of PlayPhone and CFO of StubHub.

More articles on health IT:
Prediction: Ransomware, Internet of Things dynamics to change in 2017, says Kaspersky Lab researchers
Viewpoint: Organizations that leverage AI will stay competitive
Google to develop AI team for Google Cloud

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.